Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 187 results

Search term: MF = 'C_{25}H_{33}ClN_{6}O_{3}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
8454160

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C25H33ClN6O3/c26-16-22(33)20(12-7-13-30-25(28)29)31-24(35)21(15-18-10-5-2-6-11-18)32-23(34)19(27)14-17-8-3-1-4-9-17/h1-6,8-11,19-21H,7,12-16,27H2,(H,31,35)(H,32,34)(H4,28,29,30)/t19-,20+,21+/m1/s1
C25H33ClN6O3501.0209211600
112396

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C25H33ClN6O3/c26-16-22(33)20(12-7-13-30-25(28)29)31-21(15-18-10-5-2-6-11-18)24(35)32-23(34)19(27)14-17-8-3-1-4-9-17/h1-6,8-11,19-21,31H,7,12-16,27H2,(H4,28,29,30)(H,32,34,35)/t19-,20+,21+/m1/s1
C25H33ClN6O3501.02099500
22603298

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H33ClN6O3/c1-3-27-25(34)31(12-11-30-13-15-35-16-14-30)18-24(33)32-23(19-6-8-20(26)9-7-19)17-21(28-32)22-5-4-10-29(22)2/h4-10,23H,3,11-18H2,1-2H3,(H,27,34)
C25H33ClN6O3501.02097600
22647759

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H33ClN6O3/c1-2-11-27-25(34)32(17-19-6-5-16-35-19)18-24(33)31-14-12-30(13-15-31)23-10-9-22(28-29-23)20-7-3-4-8-21(20)26/h3-4,7-10,19H,2,5-6,11-18H2,1H3,(H,27,34)
C25H33ClN6O3501.02097600
22648358

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H33ClN6O3/c1-18(2)27-25(34)32(16-19-6-5-15-35-19)17-24(33)31-13-11-30(12-14-31)23-10-9-22(28-29-23)20-7-3-4-8-21(20)26/h3-4,7-10,18-19H,5-6,11-17H2,1-2H3,(H,27,34)
C25H33ClN6O3501.02097600
2332611
InChI=1/C25H32N6O3.ClH/c1-27-22-21(23(33)28(2)25(27)34)31-16-11-20(32)30(24(31)26-22)13-6-12-29-14-9-19(10-15-29)17-18-7-4-3-5-8-18;/h3-5,7-8,19H,6,9-17H2,1-2H3;1H
C25H33ClN6O3501.020925500
23264130
InChI=1/C25H33ClN6O3/c1-17(2)35-21-15-18(34-13-5-8-32-11-9-31(3)10-12-32)14-20-23(21)25(28-16-27-20)30-24-19(26)6-7-22(29-24)33-4/h6-7,14-17H,5,8-13H2,1-4H3,(H,27,28,29,30)
C25H33ClN6O3501.02094300
22787380
InChI=1/C25H33ClN6O3/c1-35-22-6-5-19(26)15-21(22)30-9-7-29(8-10-30)17-20-16-23(33)28-25(27-20)32-13-11-31(12-14-32)24(34)18-3-2-4-18/h5-6,15-16,18H,2-4,7-14,17H2,1H3,(H,27,28,33)
C25H33ClN6O3501.02093200
76733927
InChI=1/C25H33ClN6O3/c1-34-21-3-2-18(14-20(21)26)15-28-22-19(23(33)27-7-9-31-10-12-35-13-11-31)16-29-24(30-22)32-8-6-25(17-32)4-5-25/h2-3,14,16H,4-13,15,17H2,1H3,(H,27,33)(H,28,29,30)
C25H33ClN6O3501.02093300
84437286
InChI=1/C25H32N6O3.ClH/c1-17-22(8-11-25(32)26-19-14-20(33-3)16-21(15-19)34-4)18(2)31(29-17)24-10-9-23(27-28-24)30-12-6-5-7-13-30;/h9-10,14-16H,5-8,11-13H2,1-4H3,(H,26,32);1H
C25H33ClN6O3501.02093200
25054017
InChI=1/C25H33ClN6O3/c1-18(2)17-32(23-21(26)16-28-22(15-27)29-23)30-24(33)25(3,4)19-5-7-20(8-6-19)35-14-11-31-9-12-34-13-10-31/h5-8,16,18H,9-14,17H2,1-4H3,(H,30,33)
C25H33ClN6O3501.02092200
58319967

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H33ClN6O3/c1-34-22-5-4-19(26)17-21(22)25(33)32-14-12-31(13-15-32)24-7-6-23(27-28-24)30-10-8-29(9-11-30)18-20-3-2-16-35-20/h4-7,17,20H,2-3,8-16,18H2,1H3
C25H33ClN6O3501.02092200
58322534

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C25H33ClN6O3/c26-20-3-5-21(6-4-20)35-19-25(33)32-15-13-31(14-16-32)24-8-7-23(27-28-24)30-11-9-29(10-12-30)18-22-2-1-17-34-22/h3-8,22H,1-2,9-19H2
C25H33ClN6O3501.02092200
7981786

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C25H33ClN6O3/c26-16-22(33)20(12-7-13-30-25(28)29)31-24(35)21(15-18-10-5-2-6-11-18)32-23(34)19(27)14-17-8-3-1-4-9-17/h1-6,8-11,19-21H,7,12-16,27H2,(H,31,35)(H,32,34)(H4,28,29,30)/t19-,20-,21-/m0/s1
C25H33ClN6O3501.02092100
884101
InChI=1/C25H33ClN6O3/c1-20-18-28-22(19-27-20)25(34)32(9-8-29-14-16-35-17-15-29)7-6-24(33)31-12-10-30(11-13-31)23-5-3-2-4-21(23)26/h2-5,18-19H,6-17H2,1H3
C25H33ClN6O3501.02092100
884107
InChI=1/C25H33ClN6O3/c1-20-18-28-23(19-27-20)25(34)32(8-7-29-13-15-35-16-14-29)6-5-24(33)31-11-9-30(10-12-31)22-4-2-3-21(26)17-22/h2-4,17-19H,5-16H2,1H3
C25H33ClN6O3501.02092100
8589097

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C25H33ClN6O3/c1-25(2,3)23(34)32-9-5-4-6-18(22(32)33)29-24(35)31-12-10-30(11-13-31)20-15-21(27)28-19-14-16(26)7-8-17(19)20/h7-8,14-15,18H,4-6,9-13H2,1-3H3,(H2,27,28)(H,29,35)/t18-/m0/s1
C25H33ClN6O3501.02092100
9343060

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C25H33ClN6O3/c1-14(29-23(34)25(4,5)27)11-32-13-24(2,3)35-12-20(32)22(33)31-18-9-15(26)8-17-16-6-7-28-10-19(16)30-21(17)18/h6-10,14,20,30H,11-13,27H2,1-5H3,(H,29,34)(H,31,33)/t14-,20-/m0/s1
C25H33ClN6O3501.02092100
9572825

Double-bond stereo
InChI=1/C25H33ClN6O3/c1-35-23-15-22(27)21(26)14-20(23)25(34)29-19-4-8-30(9-5-19)16-18-2-11-32(12-3-18)24(33)6-10-31-13-7-28-17-31/h6-7,10,13-15,17-19H,2-5,8-9,11-12,16,27H2,1H3,(H,29,34)/b10-6+
C25H33ClN6O3501.02092100
12345

Advertisement